473 related articles for article (PubMed ID: 16076935)
1. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
2. Free radical production induced by methamphetamine in rat striatal synaptosomes.
Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
[TBL] [Abstract][Full Text] [Related]
3. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2006 Sep; 51(4):885-95. PubMed ID: 16901518
[TBL] [Abstract][Full Text] [Related]
4. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
5. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
[TBL] [Abstract][Full Text] [Related]
6. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
Chipana C; Torres I; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2008 Jun; 54(8):1254-63. PubMed ID: 18455739
[TBL] [Abstract][Full Text] [Related]
7. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of both alpha7* and beta2* nicotinic acetylcholine receptors is necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum.
Zanetti L; de Kerchove D'Exaerde A; Zanardi A; Changeux JP; Picciotto MR; Zoli M
Psychopharmacology (Berl); 2006 Aug; 187(2):181-8. PubMed ID: 16826402
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
Northrop NA; Smith LP; Yamamoto BK; Eyerman DJ
J Pharmacol Exp Ther; 2011 Mar; 336(3):900-7. PubMed ID: 21159748
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice.
Zanetti L; Picciotto MR; Zoli M
Psychopharmacology (Berl); 2007 Feb; 190(2):189-99. PubMed ID: 17061109
[TBL] [Abstract][Full Text] [Related]
13. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
Liu Q; Xie X; Emadi S; Sierks MR; Wu J
Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
Fantegrossi WE; Ciullo JR; Wakabayashi KT; De La Garza R; Traynor JR; Woods JH
Neuroscience; 2008 Jan; 151(2):533-43. PubMed ID: 18082974
[TBL] [Abstract][Full Text] [Related]
15. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
16. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.
Tucci SA; Genn RF; File SE
Neuropharmacology; 2003 Mar; 44(3):367-73. PubMed ID: 12604094
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
18. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
19. The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
Kim MN; Jutkiewicz EM; Zhang M; Gnegy ME
Neuropharmacology; 2011 Jun; 60(7-8):1126-34. PubMed ID: 20971124
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
